These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16762001)

  • 1. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
    Bookman ID; Pham J; Guindi M; Heathcote EJ
    Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
    Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
    Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
    Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Crabb DW
    Am J Gastroenterol; 2004 Aug; 99(8):1497-502. PubMed ID: 15307867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
    Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
    Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
    Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
    Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
    Chow WC; Tai ES; Lian SC; Tan CK; Sng I; Ng HS
    Singapore Med J; 2007 Aug; 48(8):752-7. PubMed ID: 17657385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in nonalcholic fatty liver disease.
    Greenfield V; Cheung O; Sanyal AJ
    Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression, anxiety, and nonalcoholic steatohepatitis.
    Elwing JE; Lustman PJ; Wang HL; Clouse RE
    Psychosom Med; 2006; 68(4):563-9. PubMed ID: 16868265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ubiquitin levels in patients with nonalcoholic steatohepatitis.
    Savas MC; Koruk M; Pirim I; Yilmaz O; Karakok M; Taysi S; Yilmaz A
    Hepatogastroenterology; 2003; 50(51):738-41. PubMed ID: 12828075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
    Khan SH; Khan FA; Ijaz A; Sattar A; Dilawar M; Hashim R
    J Ayub Med Coll Abbottabad; 2008; 20(3):17-22. PubMed ID: 19610507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of insulin in fatty liver.
    Akçay MN; Sari A; Akçay G
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxvi-cclxxviii. PubMed ID: 15244200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.